Clinical Trial Update: Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating natural killer cell therapy plus interleukin-2 after chemotherapy in advanced melanoma and metastatic kidney cancer; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Melanoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Natural Killer cell therapy (natural killer cell therapy)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Melanoma, Metastatic Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-11-05